The Icahn School of Medicine at Mount Sinai has been awarded a grant of more than $4 million by the National Cancer Institute for a large-scale study to evaluate anal cancer screening in high-risk women who have been previously diagnosed with human papillomavirus (HPV) infection, Medical Life Sciences reports. The multi-center study is a collaboration between the Mount Sinai Anal Dysplasia Screening Program, The University of Texas MD Anderson Cancer Center, and The University of Texas Health Science Center at Houston (UTHealth). Read more.
National Cancer Institute Awards Mount Sinai $4M+ for Cancer Screening: Report
